title: Community associated MRSA: an alert to paediatricians.
abstract: Community associated methicillin resistant Staphylococcus aureus (CA-MRSA) is an emerging pathogen typically associated with skin and soft tissue infection, with occasional reports of fatality in previously healthy children and young adults. We report a case of invasive CA-MRSA and highlight the potential impact of such infections on empirical treatment of staphylococcal infections.
authors.affiliation: Guy's and St Thomas' NHS Foundation Trust, London, UK. dakshika.jeyaratnam@gstt.sthames.nhs.uk
authors.forename: D
authors.initials: D
authors.lastname: Jeyaratnam
authors.forename: C
authors.initials: C
authors.lastname: Reid
authors.forename: A
authors.initials: A
authors.lastname: Kearns
authors.forename: J
authors.initials: J
authors.lastname: Klein
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission; D004359:Drug Therapy, Combination; D005838:Genotype; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000627:therapeutic use; D012916:Soccer / Q000293:injuries*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*; D013211:Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D012293:Rifampin